The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility of a novel non-invasive technology for monitoring severe neutropenia in anticancer therapy.
 
Manuel Alva Bianchi
Honoraria - Novartis
Travel, Accommodations, Expenses - Novartis
 
Toshiaki Iwase
No Relationships to Disclose
 
Pablo Tolosa Ortega
Consulting or Advisory Role - Adamed; AstraZeneca; Daiichi Sankyo; Novartis; Seagen
Speakers' Bureau - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer; Seagen
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Pfizer
 
Pablo Justo Jiménez
No Relationships to Disclose
 
Antonia Rodriguez Izquierdo
No Relationships to Disclose
 
Tycho Baumann
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche
 
Ana Jiménez Ubieto
No Relationships to Disclose
 
Rodrigo Sanchez-Bayona
Honoraria - AstraZeneca; GlaxoSmithKline; Lilly; Novartis; Seagen
Consulting or Advisory Role - GlaxoSmithKline; Lilly; Novartis
Speakers' Bureau - AstraZeneca; Novartis
Expert Testimony - AstraZeneca; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Elizabeth Pottier
No Relationships to Disclose
 
Anthony Shelton
No Relationships to Disclose
 
José Manuel Pérez-García
No Relationships to Disclose
 
Juan Jose Garcia-Mosquera
Employment - Trialing Health
Travel, Accommodations, Expenses - Lilly
 
Alejandro Martinez-Bueno
No Relationships to Disclose
 
Ephraim P. Hochberg
Stock and Other Ownership Interests - Flatiron Health; Intervention Insights; Leuko
Honoraria - Blue Cross and Blue Shield of Massachusetts
Consulting or Advisory Role - Intervention Insights
 
Andrea Martinez
No Relationships to Disclose
 
Cesar Nunez
No Relationships to Disclose
 
David McCall
No Relationships to Disclose
 
Naoto T. Ueno
Stock and Other Ownership Interests - Pear Bio
Honoraria - Amgen; Chugai/Roche; Daiichi Sankyo; Eisai; Gilead Sciences; Henry Stewart Talks; Kyowa Hakko Kirin; Kyowa Kirin International; Novartis; Pfizer; Pfizer; Puma Biotechnology; Rakuten Medical; Sumitomo Dainippon Pharma Oncology; Sysmex; Taiho Pharmaceutical
Consulting or Advisory Role - Carna Biosciences; Daiichi Sankyo; Eisai; Immunomedics; Kechow Pharma; OncoCyte; Phoenix Molecular Designs; Preferred Medicine; Takeda
Research Funding - Amgen; Bayer; Bio-Path Holdings; Celgene; CytoDyn; Daiichi Sankyo; Duality Biologics; GlaxoSmithKline; Kyowa Hakko Kirin; Medivation; Merck; Novartis; Preferred Medicine; Puma Biotechnology; Sysmex
 
Eva M Ciruelos
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Novartis; Pfizer; Roche; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Branko Cuglievan
No Relationships to Disclose